menu
    • menu

    Company profile for Locanabio

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Locanabio is creating a new class of gene therapies able to modify dysfunctional RNA associated with a range of severe disorders including neuromuscular, neurodegenerative and retinal diseases. Our multi-functional approach is engineered to produce unique gene therapies which deliver RNA binding proteins and effector domains that target RNA across multiple mechanisms of action necessary to restore or improve health and make a ...
    Locanabio is creating a new class of gene therapies able to modify dysfunctional RNA associated with a range of severe disorders including neuromuscular, neurodegenerative and retinal diseases. Our multi-functional approach is engineered to produce unique gene therapies which deliver RNA binding proteins and effector domains that target RNA across multiple mechanisms of action necessary to restore or improve health and make a meaningful difference in patients’ lives. Creating a new class of gene therapies by targeting disease-causing messenger RNA. We are working hard to realize the potential of RNA-targeting gene therapy to treat a range.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LocanabioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3545 John Hopkins Court Suite 200 San Diego, CA 92121
    Telephone
    Telephone
    858.285.4000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://locanabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/locanabio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genetic medicines biotech to cease operations by end of year
    Genetic medicines biotech to cease operations by end of year

    02 Nov 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/locanabio-looking-new-homes-genetic-medicines-operations-set-cease-end-year

    Annalee Armstrong FIERCE BIOTECH
    02 Nov 2023
    Share Share
    Locanabio Announces Presentation of Data Showing an Improved Vectorized Platform
    Locanabio Announces Presentation of Data Showing an Improved Vectorized Platform

    06 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/06/2756042/0/en/Locanabio-Announces-Presentation-of-Preclinical-Data-Demonstrating-an-Improved-Vectorized-snRNA-Platform-with-Applications-in-Exon-Skipping-for-the-Potential-Treatment-of-Duchenne-.html

    GLOBENEWSWIRE
    06 Oct 2023
    Share Share
    Locanabio Announces Participation in Chardan™s 7th Annual Conference
    Locanabio Announces Participation in Chardan™s 7th Annual Conference

    25 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/25/2748974/0/en/Locanabio-Announces-Participation-in-Chardan-s-7th-Annual-Genetic-Medicines-Conference.html

    GLOBENEWSWIRE
    25 Sep 2023
    Share Share
    Locanabio Announces Equity Investment from CureDuchenne Ventures to Support Devp
    Locanabio Announces Equity Investment from CureDuchenne Ventures to Support Devp

    15 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/15/2668731/0/en/Locanabio-Announces-Equity-Investment-from-CureDuchenne-Ventures-to-Support-Development-of-snRNA-Exon-Skipping-Approach-for-Duchenne-Muscular-Dystrophy-DMD.html

    GLOBENEWSWIRE
    15 May 2023
    Share Share
    Locanabio Announces Presentations at the ASGCT (ASGCT) 26th Annual Meeting
    Locanabio Announces Presentations at the ASGCT (ASGCT) 26th Annual Meeting

    02 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/02/2659808/0/en/Locanabio-Announces-Presentations-at-the-American-Society-of-Gene-and-Cell-Therapy-ASGCT-26th-Annual-Meeting.html

    GLOBENEWSWIRE
    02 May 2023
    Share Share
    Locanabio Announces First Presentation of Data InvG LBIO-115 Program
    Locanabio Announces First Presentation of Data InvG LBIO-115 Program

    20 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/20/2650939/0/en/Locanabio-Announces-First-Presentation-of-Data-from-its-Next-Generation-Vectorized-snRNA-Exon-Skipping-Platform-Highlighting-its-Investigational-LBIO-115-Program-for-the-Treatment-.html

    GLOBENEWSWIRE
    20 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search